Selective Control by Pistacia vera L. and Its Carotenoid Zeaxanthin on SARS-CoV-2 Virus
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041667 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Rosamaria Pennisi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 M…. Hauptthemen laut MEDLINE: SARS-CoV-2, Zeaxanthins, Antiviral Agents, Pistacia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Pistachio Growers (APG), Fresno, CA (USA)., American Pistachio Growers (APG), Fresno, CA (USA).
Abstract (Originalsprache)
Since the onset of the COVID-19 (COronaVIrus Disease 19) pandemic, SARS-CoV-2 has exhibited a high transmission rate, further enhanced by new variants able to better adapt to humans. Addressing this issue has been challenging due to viral resistance and side effects associated with antiviral drugs and vaccines. As a result, there has been a growing interest in plant-derived compounds with antiviral properties. Our study revealed that pistachio extracts significantly inhibited SARS-CoV-2 viral entry. Employing pseudotyped particles bearing the S protein of SARS-CoV-2, we demonstrated that treatment with pistachio extracts inhibited binding of alpha (α) and omicron (ο) SARS-CoV-2 variants. Furthermore, our study revealed that the pistachio carotenoid zeaxanthin exhibited a different inhibitory activity against two SARS-CoV-2 variants. In silico analyses demonstrated a strong interaction between zeaxanthin and the receptor-binding domain (RBD) domain of the omicron spike (S) protein, thus reducing pseudovirus entry. However, zeaxanthin’s weaker interaction with the alpha variant’s RBD was insufficient to inhibit entry. Additionally, zeaxanthin suppressed the expression of the host protease TMPRSS2 at the protein level, thereby limiting the internalization of the alpha variant, which relies on TMPRSS2 for cellular entry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.
- Department of Chemistry, Materials and Chemical Engineering "G. Natta", Politecnico di Milano, Via Mancinelli 7, 20131 Milano, Italy.
- Department of Chemistry, Biology and Biotechnology, University of Perugia, Via Elce di sotto 8, 06123 Perugia, Italy.
- Department of Drug and Health Sciences, University of Catania, V. le A. Doria, 95125 Catania, Italy.
ORCID-Profile: Rosamaria Pennisi, Davide Barreca, Antonio Rescifina, Giuseppina Mandalari, Maria Teresa Sciortino
Förderung
- American Pistachio Growers (APG), Fresno, CA (USA).
- American Pistachio Growers (APG), Fresno, CA (USA)
Zitieren
APA
Pennisi, R., Gentile, D., Trischitta, P., Barreca, D., Rescifina, A., Mandalari, G., & Sciortino, M. T. (2025). Selective Control by Pistacia vera L. and Its Carotenoid Zeaxanthin on SARS-CoV-2 Virus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041667
Vancouver
Pennisi R, Gentile D, Trischitta P, Barreca D, Rescifina A, Mandalari G, et al. Selective Control by Pistacia vera L. and Its Carotenoid Zeaxanthin on SARS-CoV-2 Virus. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041667
BibTeX
@article{Pennisi2025,
author = {Pennisi, Rosamaria and Gentile, Davide and Trischitta, Paola and Barreca, Davide and Rescifina, Antonio and Mandalari, Giuseppina and Sciortino, Maria Teresa},
title = {Selective Control by Pistacia vera L. and Its Carotenoid Zeaxanthin on SARS-CoV-2 Virus},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041667}
}
EUVIMED